Single and Multiple Ascending Doses and Food Effect Study of TRD205 in Healthy Volunteers

Phase 1 Completed 151 enrolled Beijing Tide Pharmaceutical Co., Ltd

RandomizedParallel-groupDouble-blindBasic science

Summary

This is a Phase I clinical study to evaluate the safety, tolerability, and pharmacokinetics of TRD205 after single and multiple doses and to evaluate the effect of food on TRD205 in healthy adult subjects.

Timeline

Start: 2024-01-26
Primary completion: 2024-11-27
Completion: 2025-02-27

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	TRD205	Unknown	—	Oral

Indications

No indication recorded.